Literature DB >> 15373842

Testosterone 1 beta-hydroxylation by human cytochrome P450 3A4.

Joel A Krauser1, Markus Voehler, Li-Hong Tseng, Alexandre B Schefer, Markus Godejohann, F Peter Guengerich.   

Abstract

Human cytochrome P450 3A4 forms a series of minor testosterone hydroxylation products in addition to 6 beta-hydroxytestosterone, the major product. One of these, formed at the next highest rate after the 6 beta- and 2 beta-hydroxy products, was identified as 1 beta-hydroxytestosterone. This product was characterized from a mixture of testosterone oxidation products using an HPLC-solid phase extraction-cryoprobe NMR/time-of-flight mass spectrometry system, with an estimated total of approximately 6 microg of this product. Mass spectrometry established the formula as C(19)H(29)O(3) (MH(+) 305.2080). The 1-position of the added hydroxyl group was established by correlated spectroscopy and heteronuclear spin quantum correlation experiments, and the beta-stereochemistry of the added hydroxyl group was assigned with a nuclear Overhauser correlated spectroscopy experiment (1 alpha-H). Of several human P450s examined, only P450 3A4 formed this product. The product was also formed in human liver microsomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373842     DOI: 10.1111/j.1432-1033.2004.04339.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4.

Authors:  Qian Cheng; Christal D Sohl; Francis K Yoshimoto; F Peter Guengerich
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.

Authors:  Ajeeth K Pingili; Mehmet Kara; Nayaab S Khan; Anne M Estes; Zongtao Lin; Wei Li; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

3.  Untargeted analysis of mass spectrometry data for elucidation of metabolites and function of enzymes.

Authors:  Raymundo Sanchez-Ponce; F Peter Guengerich
Journal:  Anal Chem       Date:  2007-04-05       Impact factor: 6.986

4.  Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.

Authors:  Vanja Polic; Irina F Sevrioukova; Karine Auclair
Journal:  Arch Biochem Biophys       Date:  2018-06-26       Impact factor: 4.013

5.  Functional reconstitution of monomeric CYP3A4 with multiple cytochrome P450 reductase molecules in Nanodiscs.

Authors:  Yelena V Grinkova; Ilia G Denisov; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2010-06-17       Impact factor: 3.575

6.  Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2016-08-11       Impact factor: 3.739

7.  Chromatographic assays of drug oxidation by human cytochrome P450 3A4.

Authors:  Christal D Sohl; Qian Cheng; F Peter Guengerich
Journal:  Nat Protoc       Date:  2009-08-06       Impact factor: 13.491

8.  The algal hepatoxoxin okadaic acid is a substrate for human cytochromes CYP3A4 and CYP3A5.

Authors:  Fujiang Guo; Tianying An; Kathleen S Rein
Journal:  Toxicon       Date:  2009-08-20       Impact factor: 3.033

9.  Mechanism of 17α,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1: 18O LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN.

Authors:  Francis K Yoshimoto; Eric Gonzalez; Richard J Auchus; F Peter Guengerich
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

10.  Oxidase uncoupling in heme monooxygenases: human cytochrome P450 CYP3A4 in Nanodiscs.

Authors:  Yelena V Grinkova; Ilia G Denisov; Mark A McLean; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2012-12-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.